BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9216645)

  • 1. Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.
    Shiba E; Kim SJ; Kambayashi J; Kawamura I; Lacey E; Manda T; Shimomura K; Taguchi T; Takai S
    Anticancer Res; 1997; 17(3C):1919-23. PubMed ID: 9216645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells.
    Shiba E; Kim S; Fujitani M; Kambayashi JI; Kawamura I; Tsujimoto S; Shimomura K; Tanji Y; Taguchi T; Kimoto Y; Izukura M; Takai SI
    Anticancer Res; 1996; 16(2):773-7. PubMed ID: 8687127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
    Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK
    Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
    J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K
    Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-inhibitory action of an estrogen-chlorambucil conjugate (KM2210) in human breast cancer cell line MCF-7: its relation to reduction of estrogen receptor and transforming growth factor-alpha secretion.
    Kosano H; Kubota T; Ohsawa N; Yamamori S; Abe O; Inagaki H; Nagata N
    Cancer Res; 1992 Mar; 52(5):1187-91. PubMed ID: 1737378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors.
    Wimalasena J; Meehan D; Dostal R; Foster JS; Cameron M; Smith M
    Oncol Res; 1993; 5(8):325-37. PubMed ID: 8012064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.
    Clarke R; Brünner N; Katz D; Glanz P; Dickson RB; Lippman ME; Kern FG
    Mol Endocrinol; 1989 Feb; 3(2):372-80. PubMed ID: 2710138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.
    Fontana JA; Nervi C; Shao ZM; Jetten AM
    Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
    Huber M; Poulin R
    J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Hu XF; DeLuise M; Zalcberg JR
    Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.